Reprogramming Huntington monkey skin cells into pluripotent stem cells. 9 Z0 B0 Q# P5 L4 t% cChan AW, Cheng PH, Neumann A, Yang JJ. . h! Q6 c' e8 f4 O3 L $ ~! M0 @0 h9 z9 f/ OYerkes National Primate Research Center, Emory University School of Medicine, Atlanta, Georgia 30329, USA. awchan@emory.edu. h9 V& z9 ~2 P0 b+ a' R
9 L# m% ?% Q6 y: @3 OAbstract L" s6 _+ t# Q$ _, ?& IInduced pluripotent Huntington's disease monkey stem cells (rHD-iPSCs) were established by the overexpression of rhesus macaque transcription factors (Oct4, Sox2, and Klf4) in transgenic Huntington's monkey skin fibroblasts. The rHD-iPSCs were pluripotent and capable of differentiating into neuronal cell types in vitro and developed teratoma in immune compromised mice. We also demonstrated the upregulation of endogenous Oct4 and Sox2 after successful reprogramming to pluripotency in rHD-iPSCs, which was not expressed in skin fibroblasts. rHD-iPSCs also developed cellular features comparable to Huntington's disease (HD), including the accumulation of mutant huntingtin (htt) aggregate and the formation of intranuclear inclusions (NIs) paralleling neural differentiation in vitro. Induced pluripotent stem cells from transgenic HD monkeys open a new era of nonhuman primate modeling of human diseases. rHD-iPSCs that develop key HD cellular features and parallel neural differentiation can be a powerful platform for investigating the developmental impact on HD pathogenesis and developing new therapies, which can be evaluated in HD monkeys from whom the rHD-iPSCs were derived.$ b0 |1 o7 q. m& |2 v
0 c! ^' u3 h+ X! k$ |% g# H8 ^
PMID: 20936902 [PubMed - indexed for MEDLINE]PMCID: PMC2993046 [Available on 2011/10/1]1 D3 D: U+ n+ u' m+ Q9 J2 U1 v